Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Sell Stocks for Nov. 21st


Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Alvotech ALVO is a biotech company which is focused solely on the development and manufacture of biosimilar medicines for patients worldwide. The Zacks Consensus Estimate for its current year earnings has been revised almost 88.7 downward over the last 60 days.

AkzoNobel AKZOY is a leading global paints and coatings company and a major producer of specialty chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 10.1% downward over the last 60 days.

Alamo Group ALG is a leader in the design, manufacture, distribution and service of high quality equipment for infrastructure maintenance, agriculture and other applications. The Zacks Consensus Estimate for its current year earnings has been revised almost 10% downward over the last 60 days.

View the entire Zacks Rank #5 List.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Alamo Group, Inc. (ALG): Free Stock Analysis Report
 
Akzo Nobel NV (AKZOY): Free Stock Analysis Report
 
Alvotech (ALVO): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Share
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments